| Product NDC: | 60951-734 |
| Proprietary Name: | Mycophenolate Mofetil |
| Non Proprietary Name: | Mycophenolate Mofetil |
| Active Ingredient(s): | 250 mg/1 & nbsp; Mycophenolate Mofetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60951-734 |
| Labeler Name: | Qualitest Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090111 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100316 |
| Package NDC: | 60951-734-70 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (60951-734-70) |
| NDC Code | 60951-734-70 |
| Proprietary Name | Mycophenolate Mofetil |
| Package Description | 100 CAPSULE in 1 BOTTLE (60951-734-70) |
| Product NDC | 60951-734 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mycophenolate Mofetil |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100316 |
| Marketing Category Name | ANDA |
| Labeler Name | Qualitest Pharmaceuticals |
| Substance Name | MYCOPHENOLATE MOFETIL |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |